Multi-detector CT screening for lung cancer is still to be discouraged for the time being;Screenen op longkanker met de multidetector-CT: Voorlopig nog af te raden

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 3, 2008, Pages 125-128

  Van Klaveren, R J ^a   Oudkerk, M ^b   Mali, W P Th M ^c   De Koning, H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

CANCER DIAGNOSIS; CANCER PATIENT; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HUMAN; LUNG CANCER; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NOTE; OBSERVATIONAL STUDY; PUBLIC HEALTH; SURVIVAL RATE; SURVIVAL TIME;

BIAS (EPIDEMIOLOGY); COST-BENEFIT ANALYSIS; HUMANS; LUNG NEOPLASMS; MASS SCREENING; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 38849196193     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. International Early Lung Cancer Action Program Investigators. N Engl J Med. 2006;355:1763-71.
2. Beadsmoore CJ, Screaton NJ. Classification, staging and prognosis of lung cancer. Eur J Radiol. 2003;45:8-17.
3. Henschke CI. CT screening for lung cancer is justified. Nat Clin Pract Oncol. 2007;4:440-1.
4. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297:953-61.
5. Kalthofen A. Bijdrage tot het vraagstuk van primaire longkanker, op grond van ervaringen, opgedaan bij het kleinbeeld-onderzoek van 225.052 Amsterdammers. Ned Tijdschr Geneeskd. 1955;99:197-201.
6. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. J Occup Med. 1986;28:746-50.
7. Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fonatana R, Taylor WF, et al. Lung cancer mortality in the Mayo lung project: impact of extended follow-up. J Natl Cancer Inst. 2000;92:1308-16.
8. Sone S, Li F, Yang ZG, Takeshima S, Maruyama Y, Hasegawa M, et al. Characteristics of small lung cancers invisible on conventional chest radiography and detected by population based screening using spiral CT. Br J Radiol. 2000;73:137-45.
9. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. Screening for lung cancer with low-dose helical computed tomography. J Clin Oncol. 2002;20:911-20.
10. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet. 1999;354:99-105.
11. Mulshine JL, Sullivan DC. Lung cancer screening. N Engl J Med. 2005;352:2714-20.
12. Yau G, Lock M, Rodrigues G. Systematic review of baseline low-dose CT lung cancer screening. Lung Cancer. 2007;58:161-70.
13. Gleeson FV. Screening for lung cancer with spiral CT is not justified. Nat Clin Pract Oncol. 2007;4:442-3.
14. Patz jr EF, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med. 2000;343:1627-32.
15. Giard RWM. De oogst van borstkankerscreening: het belang van observationele data en de problemen van bias. Ned Tijdschr Geneeskd. 2004;148:352-5.
16. Walter SD, Kubic A, Parkin DM, Reissigova J, Adamec M, Khlat M. The natural history of lung cancer estimated from the results of a randomized trial of screening. Cancer Causes Control. 1992;3:115-23.
17. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003;95:470-8.
18. Cronin KA, Gail MH, Zou Z, Bach PB, Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst. 2006;98:637-40.
19. Smulders Y, Thijs A. Kostprijs per gewonnen levensjaar: trends en tegenstrijdigheden. Ned Tijdschr Geneeskd. 2006;150:2467-70.
20. Black C, Bagust A, Boland A, Walker S, McLeod C, de Verteuil R, et al. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technol Assess. 2006;10:1-90.
21. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers. JAMA. 2003;289:313-22.
22. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung screening study of the National Cancer Institute. Chest. 2004;126:114-21.
23. Iersel CA van, Koning HJ de, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection of the general population in a screening trial. Int J Cancer. 2007;120:868-74.